Pulmonary delivery of sirna for the treatment of cystic fibrosis and pulmonary delivery platforms

Cystic fibrosis (CF) is one of the most deadly diseases lungs that involves symptoms such as breathing difficulties, coughing and lung infection. Despite important therapeutic advances, definitive treatment for CF remains elusive. a good candidate gene therapy because it relatively common, lethal monogenic does not have adequate options. In this review article, we reviewed potential option CF. Various platforms strategies pulmonary delivery also been discussed in detail.